Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 4
1953 3
1954 1
1955 3
1956 4
1957 6
1959 1
1960 5
1961 5
1962 4
1963 6
1964 1
1965 5
1967 8
1968 1
1969 6
1970 3
1971 1
1972 1
1974 2
1975 1
1976 1
1977 1
1982 1
1983 1
1984 1
1987 2
1988 2
1989 1
1990 2
1991 2
1992 1
1993 1
1994 1
1995 5
1996 5
1997 4
1998 4
1999 6
2000 5
2001 5
2002 2
2003 6
2004 3
2005 7
2006 14
2007 11
2008 11
2009 16
2010 18
2011 13
2012 15
2013 19
2014 18
2015 16
2016 21
2017 21
2018 22
2019 22
2020 39
2021 43
2022 40
2023 44
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

499 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial.
McDermott MM, Spring B, Tian L, Treat-Jacobson D, Ferrucci L, Lloyd-Jones D, Zhao L, Polonsky T, Kibbe MR, Bazzano L, Guralnik JM, Forman DE, Rego A, Zhang D, Domanchuk K, Leeuwenburgh C, Sufit R, Smith B, Manini T, Criqui MH, Rejeski WJ. McDermott MM, et al. Among authors: rego a. JAMA. 2021 Apr 6;325(13):1266-1276. doi: 10.1001/jama.2021.2536. JAMA. 2021. PMID: 33821898 Free PMC article. Clinical Trial.
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC.
Javitt A, Shmueli MD, Kramer MP, Kolodziejczyk AA, Cohen IJ, Radomir L, Sheban D, Kamer I, Litchfield K, Bab-Dinitz E, Zadok O, Neiens V, Ulman A, Wolf-Levy H, Eisenberg-Lerner A, Kacen A, Alon M, Rêgo AT, Stacher-Priehse E, Lindner M, Koch I, Bar J, Swanton C, Samuels Y, Levin Y, da Fonseca PCA, Elinav E, Friedman N, Meiners S, Merbl Y. Javitt A, et al. Among authors: rego at. Nat Cancer. 2023 May;4(5):629-647. doi: 10.1038/s43018-023-00557-4. Epub 2023 May 22. Nat Cancer. 2023. PMID: 37217651
Mitochondrial Dysfunction in Huntington's Disease.
Carmo C, Naia L, Lopes C, Rego AC. Carmo C, et al. Among authors: rego ac. Adv Exp Med Biol. 2018;1049:59-83. doi: 10.1007/978-3-319-71779-1_3. Adv Exp Med Biol. 2018. PMID: 29427098 Review.
Modified Glutamatergic Postsynapse in Neurodegenerative Disorders.
Moraes BJ, Coelho P, Fão L, Ferreira IL, Rego AC. Moraes BJ, et al. Among authors: rego ac. Neuroscience. 2021 Feb 1;454:116-139. doi: 10.1016/j.neuroscience.2019.12.002. Epub 2019 Dec 27. Neuroscience. 2021. PMID: 31887357 Review.
Multisystemic RFC1-Related Disorder: Expanding the Phenotype Beyond Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
Malaquias MJ, Braz L, Santos Silva C, Damásio J, Jorge A, Lemos JM, Campos CF, Garcez D, Oliveira Santos M, Velon AG, Caetano A, Calejo M, Fernandes P, Rego Â, Castro S, Sousa AP, Cardoso MN, Fernandes M, Pinto MM, Taipa R, Lopes AM, Oliveira J, Magalhães M; for RFC1 Repeat Expansion National Study Group. Malaquias MJ, et al. Among authors: rego a. Neurol Clin Pract. 2023 Oct;13(5):e200190. doi: 10.1212/CPJ.0000000000200190. Epub 2023 Sep 5. Neurol Clin Pract. 2023. PMID: 37674869
499 results